| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GB:EXPN
Experian
|
Jun 10, 2026 | BUY |
Buy
+283.6% avg upside
19 analysts
|
$3500.00
36.89% Upside
|
· |
|
SE:BRAV
Bravida Holding AB
|
May 12, 2026 | HOLD |
Hold
-13.7% avg upside
1 analyst
|
$106.00
13.66% Downside
|
· |
|
FR:TEP
Teleperformance
|
Apr 29, 2026 | HOLD |
Strong Buy
+149.3% avg upside
15 analysts
|
$57.00
0.29% Downside
|
· |
|
FR:ELIS
Elis SA
|
Mar 23, 2026 | BUY |
Strong Buy
-13.1% avg upside
11 analysts
|
$30.00
11.69% Upside
|
· |
|
GB:DPLM
Diploma
|
Nov 18, 2025 | BUY |
Strong Buy
-23.2% avg upside
8 analysts
|
$6000.00
14.67% Downside
|
· |
|
GB:RTO
Rentokil Initial
|
Oct 23, 2025 | BUY |
Strong Buy
+22.1% avg upside
19 analysts
|
$505.00
14.19% Upside
|
· |
|
FR:BVI
Bureau Veritas
|
Mar 21, 2025 | HOLD |
Buy
+11.9% avg upside
24 analysts
|
$29.50
13.15% Upside
|
· |
|
CH:SGSN
SGS SA
|
Feb 17, 2025 | HOLD |
Buy
+1113.0% avg upside
25 analysts
|
$95.50
6.56% Upside
|
· |
|
GB:TPK
Travis Perkins
|
Oct 28, 2024 | BUY |
Buy
+79.8% avg upside
8 analysts
|
$1020.00
86.12% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.